These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

302 related articles for article (PubMed ID: 18215719)

  • 1. Chronic xanthine oxidase inhibition following myocardial infarction in rabbits: effects of early versus delayed treatment.
    Zhao L; Roche BM; Wessale JL; Kijtawornrat A; Lolly JL; Shemanski D; Hamlin RL
    Life Sci; 2008 Feb; 82(9-10):495-502. PubMed ID: 18215719
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Transient reduction in myocardial free oxygen radical levels is involved in the improved cardiac function and structure after long-term allopurinol treatment initiated in established chronic heart failure.
    Mellin V; Isabelle M; Oudot A; Vergely-Vandriesse C; Monteil C; Di Meglio B; Henry JP; Dautreaux B; Rochette L; Thuillez C; Mulder P
    Eur Heart J; 2005 Aug; 26(15):1544-50. PubMed ID: 15872033
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Xanthine oxidase inhibition preserves left ventricular systolic but not diastolic function in cardiac volume overload.
    Gladden JD; Zelickson BR; Guichard JL; Ahmed MI; Yancey DM; Ballinger S; Shanmugam M; Babu GJ; Johnson MS; Darley-Usmar V; Dell'Italia LJ
    Am J Physiol Heart Circ Physiol; 2013 Nov; 305(10):H1440-50. PubMed ID: 24014679
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of acute xanthine oxidase inhibition on myocardial energetics during basal and very high cardiac workstates.
    Lee J; Hu Q; Mansoor A; Kamdar F; Zhang J
    J Cardiovasc Transl Res; 2011 Aug; 4(4):504-13. PubMed ID: 21584861
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Selectivity of febuxostat, a novel non-purine inhibitor of xanthine oxidase/xanthine dehydrogenase.
    Takano Y; Hase-Aoki K; Horiuchi H; Zhao L; Kasahara Y; Kondo S; Becker MA
    Life Sci; 2005 Mar; 76(16):1835-47. PubMed ID: 15698861
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Delayed treatment effects of xanthine oxidase inhibition on systolic overload-induced left ventricular hypertrophy and dysfunction.
    Xu X; Zhao L; Hu X; Zhang P; Wessale J; Bache R; Chen Y
    Nucleosides Nucleotides Nucleic Acids; 2010 Jun; 29(4-6):306-13. PubMed ID: 20544512
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Febuxostat inhibition of endothelial-bound XO: implications for targeting vascular ROS production.
    Malik UZ; Hundley NJ; Romero G; Radi R; Freeman BA; Tarpey MM; Kelley EE
    Free Radic Biol Med; 2011 Jul; 51(1):179-84. PubMed ID: 21554948
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Allopurinol attenuates left ventricular remodeling and dysfunction after experimental myocardial infarction: a new action for an old drug?
    Engberding N; Spiekermann S; Schaefer A; Heineke A; Wiencke A; Müller M; Fuchs M; Hilfiker-Kleiner D; Hornig B; Drexler H; Landmesser U
    Circulation; 2004 Oct; 110(15):2175-9. PubMed ID: 15466649
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Xanthine oxidase inhibitors improve energetics and function after infarction in failing mouse hearts.
    Naumova AV; Chacko VP; Ouwerkerk R; Stull L; Marbán E; Weiss RG
    Am J Physiol Heart Circ Physiol; 2006 Feb; 290(2):H837-43. PubMed ID: 16183726
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Acute effects of febuxostat, a nonpurine selective inhibitor of xanthine oxidase, in pacing induced heart failure.
    Hou M; Hu Q; Chen Y; Zhao L; Zhang J; Bache RJ
    J Cardiovasc Pharmacol; 2006 Nov; 48(5):255-63. PubMed ID: 17110808
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Chronic treatment with allopurinol boosts survival and cardiac contractility in murine postischemic cardiomyopathy.
    Stull LB; Leppo MK; Szweda L; Gao WD; Marbán E
    Circ Res; 2004 Nov; 95(10):1005-11. PubMed ID: 15499028
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Inhibition of xanthine oxidase in the acute phase of myocardial infarction prevents skeletal muscle abnormalities and exercise intolerance.
    Nambu H; Takada S; Maekawa S; Matsumoto J; Kakutani N; Furihata T; Shirakawa R; Katayama T; Nakajima T; Yamanashi K; Obata Y; Nakano I; Tsuda M; Saito A; Fukushima A; Yokota T; Nio-Kobayashi J; Yasui H; Higashikawa K; Kuge Y; Anzai T; Sabe H; Kinugawa S
    Cardiovasc Res; 2021 Feb; 117(3):805-819. PubMed ID: 32402072
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Xanthine oxidase inhibitor febuxostat reduces atrial fibrillation susceptibility by inhibition of oxidized CaMKII in Dahl salt-sensitive rats.
    Xu D; Murakoshi N; Tajiri K; Duo F; Okabe Y; Murakata Y; Yuan Z; Li S; Aonuma K; Song Z; Shimoda Y; Mori H; Sato A; Nogami A; Aonuma K; Ieda M
    Clin Sci (Lond); 2021 Oct; 135(20):2409-2422. PubMed ID: 34386810
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Xanthine oxidase inhibition with febuxostat attenuates systolic overload-induced left ventricular hypertrophy and dysfunction in mice.
    Xu X; Hu X; Lu Z; Zhang P; Zhao L; Wessale JL; Bache RJ; Chen Y
    J Card Fail; 2008 Nov; 14(9):746-53. PubMed ID: 18995179
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Xanthine oxidase inhibition prevents atrial fibrillation in a canine model of atrial pacing-induced left ventricular dysfunction.
    Sakabe M; Fujiki A; Sakamoto T; Nakatani Y; Mizumaki K; Inoue H
    J Cardiovasc Electrophysiol; 2012 Oct; 23(10):1130-5. PubMed ID: 22587612
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of Allopurinol on Myocardial Energy Metabolism in Chronic Heart Failure Rats After Myocardial Infarct.
    Wang Z; Ding J; Luo X; Zhang S; Yang G; Zhu Q; Liu D
    Int Heart J; 2016 Dec; 57(6):753-759. PubMed ID: 27818481
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inhibition of xanthine oxidase reduces wasting and improves outcome in a rat model of cancer cachexia.
    Springer J; Tschirner A; Hartman K; Palus S; Wirth EK; Ruis SB; Möller N; von Haehling S; Argiles JM; Köhrle J; Adams V; Anker SD; Doehner W
    Int J Cancer; 2012 Nov; 131(9):2187-96. PubMed ID: 22336965
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Existence and participation of xanthine oxidase in reperfusion injury of ischemic rabbit myocardium.
    Terada LS; Rubinstein JD; Lesnefsky EJ; Horwitz LD; Leff JA; Repine JE
    Am J Physiol; 1991 Mar; 260(3 Pt 2):H805-10. PubMed ID: 2000975
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Xanthine oxidase inhibitors beyond allopurinol and febuxostat; an overview and selection of potential leads based on in silico calculated physico-chemical properties, predicted pharmacokinetics and toxicity.
    Šmelcerović A; Tomović K; Šmelcerović Ž; Petronijević Ž; Kocić G; Tomašič T; Jakopin Ž; Anderluh M
    Eur J Med Chem; 2017 Jul; 135():491-516. PubMed ID: 28478180
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Xanthine oxidase inhibition alleviates the cardiac complications of insulin resistance: effect on low grade inflammation and the angiotensin system.
    El-Bassossy HM; Watson ML
    J Transl Med; 2015 Mar; 13():82. PubMed ID: 25889404
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.